Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Old Dominion Freight Line
ODFL
|
+$458M |
| 2 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$248M |
| 3 |
Palo Alto Networks
PANW
|
+$163M |
| 4 |
TSMC
TSM
|
+$150M |
| 5 |
iShares MSCI Emerging Markets ex China ETF
EMXC
|
+$149M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$944M |
| 2 |
Apple
AAPL
|
+$521M |
| 3 |
Booking.com
BKNG
|
+$283M |
| 4 |
Merck
MRK
|
+$276M |
| 5 |
Procter & Gamble
PG
|
+$261M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.12% |
| 2 | Healthcare | 13.13% |
| 3 | Financials | 11.12% |
| 4 | Consumer Discretionary | 9.91% |
| 5 | Industrials | 8.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DFUS
3076
Dimensional US Equity ETF
DFUS
$21.7B
| $1.24M | ﹤0.01% |
25,707
-102
| -0.4% | -$4.64K |
|
|
QUOT
3077
DELISTED
Quotient Technology Inc
QUOT
| $1.24M | ﹤0.01% |
322,219
+1,565
| +0.5% | +$4.86K |
|
|
MACK
3078
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $1.23M | ﹤0.01% |
100,317
+25,437
| +34% | +$318K |
|
3079
Harvard Bioscience
HBIO
$30.5M
| $1.23M | ﹤0.01% |
22,424
+8,969
| +67% | +$492K |
|
3080
Axogen
AXGN
$2.6B
| $1.23M | ﹤0.01% |
134,824
+3,146
| +2% | +$29.3K |
|
3081
FlexShares Global Upstream Natural Resources Index Fund
GUNR
$7.04B
| $1.23M | ﹤0.01% |
30,695
-13,777
| -31% | -$568K |
|
3082
Solid Power
SLDP
$548M
| $1.22M | ﹤0.01% |
480,122
+54,308
| +13% | +$125K |
|
3083
ORIX
IX
$43.6B
| $1.22M | ﹤0.01% |
66,685
+2,820
| +4% | +$48.9K |
|
3084
iShares MSCI Pacific ex Japan ETF
EPP
$2.24B
| $1.21M | ﹤0.01% |
28,739
+15,200
| +112% | +$658K |
|
3085
Willdan Group
WLDN
$1.31B
| $1.21M | ﹤0.01% |
63,330
-65
| -0.1% | -$1.09K |
|
3086
Liberty Latin America Class A
LILA
$1.67B
| $1.21M | ﹤0.01% |
203,367
-551
| -0.3% | -$3.08K |
|
|
NNDM
3087
Nano Dimension
NNDM
$342M
| $1.21M | ﹤0.01% |
418,025
+351,885
| +532% | +$872K |
|
3088
SEACOR Marine Holdings
SMHI
$264M
| $1.21M | ﹤0.01% |
105,686
+61,545
| +139% | +$545K |
|
3089
Cato Corp
CATO
$67.5M
| $1.21M | ﹤0.01% |
150,420
-974
| -0.6% | -$8.08K |
|
3090
Inogen
INGN
$153M
| $1.21M | ﹤0.01% |
104,500
-85,806
| -45% | -$1.01M |
|
3091
eGain
EGAN
$205M
| $1.21M | ﹤0.01% |
160,890
-3,285
| -2% | -$23.9K |
|
3092
Blink Charging
BLNK
$84.5M
| $1.2M | ﹤0.01% |
201,122
+41,796
| +26% | +$289K |
|
|
SLGC
3093
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| $1.2M | ﹤0.01% |
520,586
-26,099
| -5% | -$73.7K |
|
3094
Atea Pharmaceuticals
AVIR
$411M
| $1.2M | ﹤0.01% |
321,305
+11,746
| +4% | +$44K |
|
3095
Superior Group of Companies
SGC
$205M
| $1.19M | ﹤0.01% |
127,871
-32,352
| -20% | -$271K |
|
3096
Zymeworks
ZYME
$1.77B
| $1.18M | ﹤0.01% |
+137,100
| New | +$1.23M |
|
3097
Karyopharm Therapeutics
KPTI
$45.3M
| $1.18M | ﹤0.01% |
44,041
+13,743
| +45% | +$592K |
|
|
FFWM
3098
DELISTED
First Foundation Inc
FFWM
| $1.18M | ﹤0.01% |
297,480
-23,809
| -7% | -$123K |
|
3099
Tenaya Therapeutics
TNYA
$165M
| $1.18M | ﹤0.01% |
201,114
+73,174
| +57% | +$425K |
|
3100
Methanex
MEOH
$4.33B
| $1.18M | ﹤0.01% |
28,536
-1,089
| -4% | -$47K |
|
Similar funds
Bank of New York Mellon's Q2 2023 Portfolio in Review
As of Q2 2023, Bank of New York Mellon held 4,580 positions worth $476B, up 4.2% from $457B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Bank of New York Mellon's Q2 2023 filing shows 192 new, 1,611 increased, 2,315 reduced and 201 closed positions. Its largest new stake was Kenvue: 4,155,782 shares worth $110M. The largest sale was Microsoft, an estimated $944M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
- Bank of New York Mellon's largest Q2 2023 buy was Kenvue: 4,155,782 shares worth $110M.
- Bank of New York Mellon added most to Old Dominion Freight Line in Q2 2023, an estimated $458M increase.
- Bank of New York Mellon's biggest Q2 2023 reduction was Microsoft, cutting an estimated $944M.
- Bank of New York Mellon fully exited Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6.00% Mandatory Convertible Preferred Stock, Series B in Q2 2023, selling an estimated $57.6M.
- Bank of New York Mellon's ten largest holdings make up 21% of its $476B portfolio in Q2 2023.
- Bank of New York Mellon opened 192 new positions and closed 201 in Q2 2023.
- Bank of New York Mellon's portfolio value rose 4.2% quarter-over-quarter to $476B.
Based on Bank of New York Mellon's 13F filing for Q2 2023, filed 3 Aug 2023.